Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer ...
OxyContin maker Purdue Pharma urged a bankruptcy judge on Wednesday to approve a restructuring plan that includes a $7.4 ...
NEW YORK, Oct 21 (Reuters) - More than 99% of bankrupt drugmaker Purdue Pharma's creditors voted to accept a $7.4 billion settlement of legal claims related to the company's sales of addictive opioid ...
(Bloomberg) -- Creditors of Purdue Pharma voted in favor of the opioid maker’s proposal to exit bankruptcy and pay billions to communities and individuals who say they were harmed by the company’s ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. The attorneys general for eight holdout ...
STAMFORD, Conn.--(BUSINESS WIRE)--Purdue Pharma L.P. (“Purdue”) today announced that its Chapter 11 Plan of Reorganization (“Plan”) received support from more than 99% of voting creditors, based on ...
The company that makes the prescription painkiller OxyContin would be transformed into a new entity that would funnel profits into combatting the U.S. opioid crisis under a $10 billion plan submitted ...
CHICAGO (WLS) -- ABC7's Tanja Babich takes a look at your top stories for Monday, Sept. 16. Purdue Pharma, the company that made billions selling the prescription painkiller OxyContin has filed for ...
Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback